Germany, US in hot pursuit of ‘messenger’ drug molecules

A molecule that carries the recipe for making drugs inside body cells is exciting scientists and investors alike, attracting hundreds of millions of dollars in a scramble for the next promising area of biotechnology.

German and US firms are leading the way in synthetic messenger RNA, or mRNA technology, a new approach to tackling a range of hard-to-treat diseases.

In theory, the promise of mRNA is enormous, ranging from cancer to infectious diseases to heart and kidney disorders, since it could be used to tackle the 80 percent of proteins that are difficult to affect with existing medicines.

Despite a recent sell-off in biotech stocks, sparked by US Democratic Presidential candidate Hillary Clinton’s threat to crack down on drug pricing, enthusiasm for mRNA, is rising.

Check Also

Novo Nordisk raises awareness about diabetes

(Saykot Murtaza): Novo Nordisk, a Danish multinational pharmaceutical company, will observe World Health Day on …

Leave a Reply

Your email address will not be published. Required fields are marked *